Cargando…

The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation

PURPOSE: To investigate the effects of the selective NLRP3 inflammasome inhibitor MCC950 on post-resuscitation myocardial function and survival in a rat model of cardiopulmonary resuscitation (CPR). METHODS: Thirty-six Sprague Dawley rats were randomized into three groups: (1) MCC950, (2) control, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Guanghui, He, Fenglian, Xu, Jing, Hu, Juntao, Ge, Weiwei, Ji, Xianfei, Wang, Changsheng, Bradley, Jennifer L., Peberdy, Mary Ann, Ornato, Joseph P., Jiang, Longyuan, Toldo, Stefano, Wang, Tong, Tang, Wanchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164003/
https://www.ncbi.nlm.nih.gov/pubmed/34973094
http://dx.doi.org/10.1007/s10557-021-07282-z
_version_ 1785037998810726400
author Zheng, Guanghui
He, Fenglian
Xu, Jing
Hu, Juntao
Ge, Weiwei
Ji, Xianfei
Wang, Changsheng
Bradley, Jennifer L.
Peberdy, Mary Ann
Ornato, Joseph P.
Jiang, Longyuan
Toldo, Stefano
Wang, Tong
Tang, Wanchun
author_facet Zheng, Guanghui
He, Fenglian
Xu, Jing
Hu, Juntao
Ge, Weiwei
Ji, Xianfei
Wang, Changsheng
Bradley, Jennifer L.
Peberdy, Mary Ann
Ornato, Joseph P.
Jiang, Longyuan
Toldo, Stefano
Wang, Tong
Tang, Wanchun
author_sort Zheng, Guanghui
collection PubMed
description PURPOSE: To investigate the effects of the selective NLRP3 inflammasome inhibitor MCC950 on post-resuscitation myocardial function and survival in a rat model of cardiopulmonary resuscitation (CPR). METHODS: Thirty-six Sprague Dawley rats were randomized into three groups: (1) MCC950, (2) control, and (3) sham. Each group consisted of a 6 h non-survival subgroup (n = 6) and a 48 h survival subgroup (n = 6). Ventricular fibrillation (VF) was induced and untreated for 6 min. CPR was initiated and continued for 8 min. Resuscitation was attempted with a 4 J defibrillation. MCC950 (10 mg/kg) or vehicle was administered via intraperitoneal injection immediately after the return of spontaneous circulation (ROSC). Myocardial function and sublingual microcirculation were measured after ROSC in the non-survival subgroups. Plasma levels of interleukin Iβ (IL-1β) and cardiac troponin I (cTnI) were measured at baseline and 6 h in the non-survival subgroups. Heart tissue was harvested to measure the NLRP3 inflammasome constituents, including NLRP3, apoptosis-associated speck-like protein (ASC), Caspase-1, and IL-1β. Survival duration and neurologic deficit score (NDS) were recorded and evaluated among survival groups. RESULTS: Post-resuscitation myocardial function and sublingual microcirculation were improved in MCC950 compared with control (p < 0.05). IL-1β and cTnI were decreased in MCC950 compared to control (p < 0.01). The MCC950 treated groups showed significantly reduced ASC, caspase-1, and IL-1β compared with the control group (p < 0.05). Survival at 48 h after ROSC was greater in MCC950 (p < 0.05) with improved NDS (p < 0.05). CONCLUSION: Administration of MCC950 following ROSC mitigates post-resuscitation myocardial dysfunction and improves survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10557-021-07282-z.
format Online
Article
Text
id pubmed-10164003
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-101640032023-05-08 The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation Zheng, Guanghui He, Fenglian Xu, Jing Hu, Juntao Ge, Weiwei Ji, Xianfei Wang, Changsheng Bradley, Jennifer L. Peberdy, Mary Ann Ornato, Joseph P. Jiang, Longyuan Toldo, Stefano Wang, Tong Tang, Wanchun Cardiovasc Drugs Ther Original Article PURPOSE: To investigate the effects of the selective NLRP3 inflammasome inhibitor MCC950 on post-resuscitation myocardial function and survival in a rat model of cardiopulmonary resuscitation (CPR). METHODS: Thirty-six Sprague Dawley rats were randomized into three groups: (1) MCC950, (2) control, and (3) sham. Each group consisted of a 6 h non-survival subgroup (n = 6) and a 48 h survival subgroup (n = 6). Ventricular fibrillation (VF) was induced and untreated for 6 min. CPR was initiated and continued for 8 min. Resuscitation was attempted with a 4 J defibrillation. MCC950 (10 mg/kg) or vehicle was administered via intraperitoneal injection immediately after the return of spontaneous circulation (ROSC). Myocardial function and sublingual microcirculation were measured after ROSC in the non-survival subgroups. Plasma levels of interleukin Iβ (IL-1β) and cardiac troponin I (cTnI) were measured at baseline and 6 h in the non-survival subgroups. Heart tissue was harvested to measure the NLRP3 inflammasome constituents, including NLRP3, apoptosis-associated speck-like protein (ASC), Caspase-1, and IL-1β. Survival duration and neurologic deficit score (NDS) were recorded and evaluated among survival groups. RESULTS: Post-resuscitation myocardial function and sublingual microcirculation were improved in MCC950 compared with control (p < 0.05). IL-1β and cTnI were decreased in MCC950 compared to control (p < 0.01). The MCC950 treated groups showed significantly reduced ASC, caspase-1, and IL-1β compared with the control group (p < 0.05). Survival at 48 h after ROSC was greater in MCC950 (p < 0.05) with improved NDS (p < 0.05). CONCLUSION: Administration of MCC950 following ROSC mitigates post-resuscitation myocardial dysfunction and improves survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10557-021-07282-z. Springer US 2022-01-01 2023 /pmc/articles/PMC10164003/ /pubmed/34973094 http://dx.doi.org/10.1007/s10557-021-07282-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Zheng, Guanghui
He, Fenglian
Xu, Jing
Hu, Juntao
Ge, Weiwei
Ji, Xianfei
Wang, Changsheng
Bradley, Jennifer L.
Peberdy, Mary Ann
Ornato, Joseph P.
Jiang, Longyuan
Toldo, Stefano
Wang, Tong
Tang, Wanchun
The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation
title The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation
title_full The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation
title_fullStr The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation
title_full_unstemmed The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation
title_short The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation
title_sort selective nlrp3-inflammasome inhibitor mcc950 mitigates post-resuscitation myocardial dysfunction and improves survival in a rat model of cardiac arrest and resuscitation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164003/
https://www.ncbi.nlm.nih.gov/pubmed/34973094
http://dx.doi.org/10.1007/s10557-021-07282-z
work_keys_str_mv AT zhengguanghui theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT hefenglian theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT xujing theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT hujuntao theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT geweiwei theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT jixianfei theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT wangchangsheng theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT bradleyjenniferl theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT peberdymaryann theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT ornatojosephp theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT jianglongyuan theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT toldostefano theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT wangtong theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT tangwanchun theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT zhengguanghui selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT hefenglian selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT xujing selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT hujuntao selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT geweiwei selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT jixianfei selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT wangchangsheng selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT bradleyjenniferl selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT peberdymaryann selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT ornatojosephp selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT jianglongyuan selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT toldostefano selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT wangtong selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation
AT tangwanchun selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation